2013 Vascular Cell Biology Gordon Research Conference
2013年血管细胞生物学戈登研究会议
基本信息
- 批准号:8451156
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-22 至 2014-01-21
- 项目状态:已结题
- 来源:
- 关键词:AreaAtherosclerosisBindingBiologicalBiologyBiomechanicsBlood VesselsCardiologyCardiovascular DiseasesCell CommunicationCellsCellular biologyChronicClinicalCollaborationsDataDevelopmentDiabetes MellitusDisciplineDiseaseEpigenetic ProcessFeedbackFosteringFundingFunding ApplicantGeneticGenomicsGoalsGrowthHealthHomeostasisHumanHypertensionImmuneImmune System DiseasesImmunologyInflammatoryInternal MedicineKnowledgeLeadMalariaMalignant NeoplasmsMolecularMyocardial InfarctionNatureNeurologicParticipantPathologyPatternPulmonary HypertensionRegulationRequest for ProposalsResearchResearch PersonnelScienceScientistSignal PathwaySignal TransductionStagingStrokeSystemTherapeuticTrainingTranslatingVascular DiseasesVascular SystemWorkabstractingbody systemcareerclinically relevantdesignexperiencefrontierhuman diseaseimprovedinsightlipid mediatormalformationmeetingsmultidisciplinarynew therapeutic targetnovelnovel therapeuticsoncologyplanetary Atmosphereposterspublic health relevanceregenerativestem cell biologysymposium
项目摘要
DESCRIPTION (provided by applicant): Funds are requested to support the Gordon Research Conference on "Vascular Cell Biology" to be held Jan 27- Feb 1, 2013 in Ventura, CA. Vascular biology is an emerging discipline which has provided important insights into our understanding of most if not all organ systems. Vascular biology research has been translated into many clinical disciplines such as oncology, internal medicine and cardiology. Importantly, current vascular research promises to lead to novel insights of disease mechanisms and novel therapeutic targets of important diseases such as cancer, ischemic cardiovascular diseases, chronic inflammatory diseases, diabetes, congenital vascular diseases and neurological conditions. The conference will cover a range of cutting-edge topics including developmental signals and vascular malformations, frontiers in genetics and genomics, pathobiology of gaseous and lipid mediator signals, regenerative / stem cell biology, matrix and biomechanical signaling, cell biological frontiers, novel therapeutics and vascular immunology. The meeting will bring together speakers, discussants and participants who represent a wide range of disciplines, approaches and systems- thus promoting interdisciplinary discussions and insights. The small size of the conference and the informal atmosphere will facilitate discussion and interactions. Young investigators and trainees will have ample opportunities to discuss science and to network with senior colleagues who are leaders in their fields. Major advances in our understanding of regulatory mechanisms in vascular biology, especially new insights into cell-cell communication and vascular disturbances in various diseases as well as critical analysis of the current state of therapeutics make this a particularly timely and scientifically exciting meeting.
描述(由申请人提供):资金要求支持戈登研究会议上的“血管细胞生物学”将于2013年1月27日至2月1日在文图拉,加利福尼亚州。血管生物学是一门新兴的学科,它为我们理解大多数(如果不是所有)器官系统提供了重要的见解。血管生物学研究已转化为许多临床学科,如肿瘤学,内科学和心脏病学。重要的是,目前的血管研究有望导致疾病机制的新见解和重要疾病的新治疗靶点,如癌症,缺血性心血管疾病,慢性炎症性疾病,糖尿病,先天性血管疾病和神经系统疾病。会议将涵盖一系列前沿主题,包括发育信号和血管畸形,遗传学和基因组学前沿,气体和脂质介体信号的病理生物学,再生/干细胞生物学,基质和生物力学信号,细胞生物学前沿,新型疗法和血管免疫学。会议将汇集代表广泛学科、方法和系统的发言者、讨论者和与会者,从而促进跨学科讨论和见解。会议规模小,非正式的气氛将有利于讨论和互动。年轻的研究人员和受训人员将有充分的机会讨论科学问题,并与在各自领域处于领先地位的资深同事建立联系。我们对血管生物学调控机制的理解取得了重大进展,特别是对各种疾病中细胞间通讯和血管紊乱的新见解,以及对当前治疗学状态的批判性分析,使这成为一个特别及时和科学上令人兴奋的会议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy Tun Hla其他文献
Timothy Tun Hla的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy Tun Hla', 18)}}的其他基金
Myeloid sphingolipid regulation of tissue resolution and regeneration responses
骨髓鞘脂对组织分辨率和再生反应的调节
- 批准号:
10562518 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Myeloid sphingolipid regulation of tissue resolution and regeneration responses
骨髓鞘脂对组织分辨率和再生反应的调节
- 批准号:
10708956 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Sphingolipid signaling in age-associated vascular pathology
年龄相关血管病理学中的鞘脂信号传导
- 批准号:
10506516 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
G protein-coupled receptor regulation of transcriptional mechanisms in the retinal vasculature.
G 蛋白偶联受体对视网膜脉管系统转录机制的调节。
- 批准号:
10596099 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
G protein-coupled receptor regulation of transcriptional mechanisms in the retinal vasculature.
G 蛋白偶联受体对视网膜脉管系统转录机制的调节。
- 批准号:
10390409 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
G protein-coupled receptor regulation of transcriptional mechanisms in the retinal vasculature.
G 蛋白偶联受体对视网膜脉管系统转录机制的调节。
- 批准号:
10204421 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Sphingolipid signaling in age-associated vascular pathology
年龄相关血管病理学中的鞘脂信号传导
- 批准号:
10253131 - 财政年份:2020
- 资助金额:
$ 1万 - 项目类别:
Mechanisms of sphingolipid signaling in vascular health and disease
血管健康和疾病中鞘脂信号传导的机制
- 批准号:
10536682 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
Mechanisms of sphingolipid signaling in vascular health and disease
血管健康和疾病中鞘脂信号传导的机制
- 批准号:
9244438 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
Mechanisms of sphingolipid signaling in vascular health and disease
血管健康和疾病中鞘脂信号传导的机制
- 批准号:
10091507 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
相似海外基金
A lipid-induced RNA-binding protein in atherosclerosis
动脉粥样硬化中脂质诱导的 RNA 结合蛋白
- 批准号:
10363664 - 财政年份:2020
- 资助金额:
$ 1万 - 项目类别:
A lipid-induced RNA-binding protein in atherosclerosis
动脉粥样硬化中脂质诱导的 RNA 结合蛋白
- 批准号:
10586123 - 财政年份:2020
- 资助金额:
$ 1万 - 项目类别:
Functional analysis of ApoA-I/HDL binding protein for the treatment of atherosclerosis(Fostering Joint International Research)
ApoA-I/HDL结合蛋白治疗动脉粥样硬化的功能分析(促进国际联合研究)
- 批准号:
16KK0203 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research)
Development of diagnostic method for atherosclerosis targeting adipokine binding proteins
开发针对脂肪因子结合蛋白的动脉粥样硬化诊断方法
- 批准号:
15H04762 - 财政年份:2015
- 资助金额:
$ 1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of a novel IL18 binding protein in atherosclerosis
新型 IL18 结合蛋白在动脉粥样硬化中的作用
- 批准号:
8882740 - 财政年份:2015
- 资助金额:
$ 1万 - 项目类别:
Role of a novel IL18 binding protein in atherosclerosis
新型 IL18 结合蛋白在动脉粥样硬化中的作用
- 批准号:
9130248 - 财政年份:2015
- 资助金额:
$ 1万 - 项目类别:
Progranulin, a Novel HDL-Binding Protein, Suppresses Systemic Inflammation, Glucose Abnormality and Atherosclerosis
颗粒体蛋白前体是一种新型 HDL 结合蛋白,可抑制全身炎症、血糖异常和动脉粥样硬化
- 批准号:
24390233 - 财政年份:2012
- 资助金额:
$ 1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
S100A8/9 calcium binding proteins enhances myeloid cell proliferation and impairs atherosclerosis regression in diabetes
S100A8/9 钙结合蛋白增强骨髓细胞增殖并损害糖尿病患者的动脉粥样硬化消退
- 批准号:
252764 - 财政年份:2012
- 资助金额:
$ 1万 - 项目类别: